An interventional study of cross-modal sensory stimulation in Cerebral Palsy and Cortical Visual Impairment, sponsored by Sheba Medical Center. Completed at 1 site in Israel. Open to participants aged 2 Years to 21 Years. Per ClinicalTrials.gov, last updated 2010-11-03.
Sponsored by Sheba Medical Center · Not applicable, Interventional, and Treatment
This study will investigate the effect of enhanced visual and cross-modal environments upon the visual attentiveness of multiply handicapped children diagnosed with Cerebral Palsy (CP) and Cortical Visual Impairment (CVI).
Research Hypothesis
Use of Noldus: The Observer, an advanced objective computerized observation program, will enable precise detection of the neurobehavioral responses of the participants. Both overt and covert responses will be observed, analyzed and correlated to identify the level of attention of each participant.
1,853 studies on the registry are indexed under Cerebral Palsy; 435 are open to participants now.
This study's enrollment of 60 is above the median of 33 across 1,368 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Sheba Medical Center is the lead sponsor of 660 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Diagnosis: CP, moderate to severe MR and CVI
Behavioral: cross-modal sensory stimulation
Diagnosis: CP, Moderate to severe MR, no visual impairment
Behavioral: cross-modal sensory stimulation
comparison of participant response to unimodal visual stimulation and to bimodal sensory stimulation
Eye Movements
Time frame: within the testing session
Other behavioural responses
Time frame: within the testing session
This study is completed, as verified in Nov 2010. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sheba Medical Center